法律人 LawPlayer logo

資料由法律人 LawPlayer整理提供·EU law / curated by LawPlayer from EUR-Lex

Regulation

Commission Implementing Regulation (EU) 2024/2848 of 11 November 2024 amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances fenpyrazamine and flumetralin

CELEX
Implementing Regulation (EU) 2024/2848
Date of document
Articles
3
Source
EUR-Lex
Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in Part B, in row 25, fenpyrazamine, in the sixth column, ‘Expiration of approval’, the date is replaced by ‘15 January 2025’;

(2)

in Part E, in row 1, flumetralin, in the sixth column, ‘Expiration of approval’, the date is replaced by ‘15 January 2025’.

3 articles

Cite this act

Commission Implementing Regulation (EU) 2024/2848 of 11 November 2024 amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances fenpyrazamine and flumetralin (EUR-Lex). Retrieved via LawPlayer, https://lawplayer.com/eu/act/32024R2848

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

EU-EurLex-Reuse-2011-833

本頁資料來源:EUR-Lex·整理提供:法律人 LawPlayer· lawplayer.com